GIM
GMED icon

Glenmede Investment Management’s Globus Medical GMED Stock Holding History

Glenmede Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11.5M Sell
200,236
-6,607
-3% -$380K 0.06% 323
2025
Q2 		$12.2M Buy
+206,843
New +$13.4M 0.06% 308

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Glenmede Investment Management's GMED Position: Q3 2025 in Review

Glenmede Investment Management reduced its Globus Medical (GMED) stake by 3.2% in Q3 2025, selling an estimated $380K and leaving 200,236 shares worth $11.5M. The position accounts for 0.06% of the portfolio, ranked #323.

Glenmede Investment Management first reported a position in GMED in Q2 2025 and has held it in 2 quarters since. The position peaked at $12.2M in Q2 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Glenmede Investment Management held 200,236 shares of Globus Medical worth $11.5M as of Q3 2025.
  • Glenmede Investment Management sold 6,607 Globus Medical shares in Q3 2025, an estimated $380K.
  • Globus Medical made up 0.06% of Glenmede Investment Management's portfolio in Q3 2025, its #323 holding.
  • Glenmede Investment Management first reported a position in Globus Medical in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Globus Medical position peaked at $12.2M in Q2 2025.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.